ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 into First-In-Human Clinical Study
August 22, 2019 11:54 ET | ONL Therapeutics
ANN ARBOR, Mich., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today...
ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 into First-In-Human Clinical Study
August 22, 2019 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today...
ONL Therapeutics Names Industry Veteran as CEO as Company Prepares for First in Human Clinical Trials
June 18, 2019 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., June 18, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving vision in a range of retinal diseases, today...
Shareholder Update Q3 2018
October 02, 2018 00:00 ET | Factor Therapeutics
Highlights: Venous leg ulcer Phase 2 trial on track:  top-line results mid-NovemberDiabetic foot ulcer pilot clinical study: in development with key US researchersOcular wounds: international patent...
EQUITY ALERT UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Against Ocular Therapeutix, Inc. - OCUL
August 10, 2017 18:03 ET | The Rosen Law Firm PA
NEW YORK, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Ocular Therapeutix, Inc....
Insight Pharma Reports' Gene Therapy Market Report: Moving Toward Commercialization
September 23, 2016 13:00 ET | Insight Pharma Reports
NEEDHAM, MA--(Marketwired - September 23, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, releases "Gene Therapy: Moving Toward Commercialization" an in-depth life science market...
Keynote Speaker and Final Agenda Announced for Targeting Ocular Disorders 2016
June 02, 2016 13:00 ET | Cambridge Healthtech Institute
NEEDHAM, MA--(Marketwired - June 02, 2016) - Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, announced the speaker lineup and final agenda for the...
Gene Therapy: Moving Toward Commercialization
May 11, 2016 10:50 ET | Insight Pharma Reports
NEEDHAM, MA--(Marketwired - May 11, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, releases "Gene Therapy: Moving Toward Commercialization" an in-depth life science market...